Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status.

Hüsing A, Canzian F, Beckmann L, Garcia-Closas M, Diver WR, Thun MJ, Berg CD, Hoover RN, Ziegler RG, Figueroa JD, Isaacs C, Olsen A, Viallon V, Boeing H, Masala G, Trichopoulos D, Peeters PH, Lund E, Ardanaz E, Khaw KT, Lenner P, Kolonel LN, Stram DO, Le Marchand L, McCarty CA, Buring JE, Lee IM, Zhang S, Lindström S, Hankinson SE, Riboli E, Hunter DJ, Henderson BE, Chanock SJ, Haiman CA, Kraft P, Kaaks R; BPC3.

J Med Genet. 2012 Sep;49(9):601-8. doi: 10.1136/jmedgenet-2011-100716.

2.

11q13 is a susceptibility locus for hormone receptor positive breast cancer.

Lambrechts D, Truong T, Justenhoven C, Humphreys MK, Wang J, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Cornelissen S, van Hien R, Sawyer E, Tomlinson I, Kerin M, Miller N, Milne RL, Zamora MP, Pérez JI, Benítez J, Hamann U, Ko YD, Brüning T; GENICA Network, Chang-Claude J, Eilber U, Hein R, Nickels S, Flesch-Janys D, Wang-Gohrke S, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Chenevix-Trench G, Beesley J, Chen X; Investigators kConFab; Australian Ovarian Cancer Study Group, Menegaux F, Cordina-Duverger E, Shen CY, Yu JC, Wu PE, Hou MF, Andrulis IL, Selander T, Glendon G, Mulligan AM, Anton-Culver H, Ziogas A, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Jones M, Orr N, Ashworth A, Swerdlow A, Severi G, Baglietto L, Giles G, Southey M, Marmé F, Schneeweiss A, Sohn C, Burwinkel B, Yesilyurt BT, Neven P, Paridaens R, Wildiers H, Brenner H, Müller H, Arndt V, Stegmaier C, Meindl A, Schott S, Bartram CR, Schmutzler RK, Cox A, Brock IW, Elliott G, Cross SS, Fasching PA, Schulz-Wendtland R, Ekici AB, Beckmann MW, Fletcher O, Johnson N, Silva Idos S, Peto J, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Dörk T, Schürmann P, Bremer M, Hillemanns P, Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Khusnutdinova E, Bermisheva M, Prokofieva D, Gancev S, Jakubowska A, Lubinski J, Jaworska K, Durda K, Nordestgaard BG, Bojesen SE, Lanng C, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Radice P, Peterlongo P, Manoukian S, Bernard L, Couch FJ, Olson JE, Wang X, Fredericksen Z, Alnaes GG, Kristensen V, Børresen-Dale AL, Devilee P, Tollenaar RA, Seynaeve CM, Hooning MJ, García-Closas M, Chanock SJ, Lissowska J, Sherman ME, Hall P, Liu J, Czene K, Kang D, Yoo KY, Noh DY, Lindblom A, Margolin S, Dunning AM, Pharoah PD, Easton DF, Guénel P, Brauch H.

Hum Mutat. 2012 Jul;33(7):1123-32. doi: 10.1002/humu.22089. Epub 2012 Apr 30.

3.

Genetic susceptibility loci for subtypes of breast cancer in an African American population.

Palmer JR, Ruiz-Narvaez EA, Rotimi CN, Cupples LA, Cozier YC, Adams-Campbell LL, Rosenberg L.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):127-34. doi: 10.1158/1055-9965.EPI-12-0769. Epub 2012 Nov 7.

4.

Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.

Chen Q, Shi R, Liu W, Jiang D.

PLoS One. 2013 Aug 16;8(8):e72487. doi: 10.1371/journal.pone.0072487. eCollection 2013.

5.

Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.

Chan M, Ji SM, Liaw CS, Yap YS, Law HY, Yoon CS, Wong CY, Yong WS, Wong NS, Ng R, Ong KW, Madhukumar P, Oey CL, Tan PH, Li HH, Ang P, Ho GH, Lee AS.

Breast Cancer Res Treat. 2012 Nov;136(1):209-20. doi: 10.1007/s10549-012-2234-y. Epub 2012 Sep 11.

PMID:
22965832
6.

Common breast cancer susceptibility loci are associated with triple-negative breast cancer.

Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, Fasching PA, Miron P, Eccles D, Carpenter JE, Godwin AK, Ambrosone C, Winqvist R, Brauch H; GENICA consortium, Schmidt MK, Cox A, Cross SS, Sawyer E, Hartmann A, Beckmann MW, Schulz-Wendtland R, Ekici AB, Tapper WJ, Gerty SM, Durcan L, Graham N, Hein R, Nickels S, Flesch-Janys D, Heinz J, Sinn HP, Konstantopoulou I, Fostira F, Pectasides D, Dimopoulos AM, Fountzilas G, Clarke CL, Balleine R, Olson JE, Fredericksen Z, Diasio RB, Pathak H, Ross E, Weaver J, Rüdiger T, Försti A, Dünnebier T, Ademuyiwa F, Kulkarni S, Pylkäs K, Jukkola-Vuorinen A, Ko YD, Van Limbergen E, Janssen H, Peto J, Fletcher O, Giles GG, Baglietto L, Verhoef S, Tomlinson I, Kosma VM, Beesley J, Greco D, Blomqvist C, Irwanto A, Liu J, Blows FM, Dawson SJ, Margolin S, Mannermaa A, Martin NG, Montgomery GW, Lambrechts D, dos Santos Silva I, Severi G, Hamann U, Pharoah P, Easton DF, Chang-Claude J, Yannoukakos D, Nevanlinna H, Wang X, Couch FJ.

Cancer Res. 2011 Oct 1;71(19):6240-9. doi: 10.1158/0008-5472.CAN-11-1266. Epub 2011 Aug 15.

7.

Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.

Slattery ML, Baumgartner KB, Giuliano AR, Byers T, Herrick JS, Wolff RK.

Breast Cancer Res Treat. 2011 Sep;129(2):531-9. doi: 10.1007/s10549-011-1498-y. Epub 2011 Apr 8.

8.

Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population.

Deng Z, Yang H, Liu Q, Wang Z, Feng T, Ouyang Y, Jin T, Ren H.

J Hum Genet. 2016 Dec;61(12):1027-1034. doi: 10.1038/jhg.2016.97. Epub 2016 Sep 8.

PMID:
27604554
9.

Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.

Liang J, Chen P, Hu Z, Shen H, Wang F, Chen L, Li M, Tang J, Wang H, Shen H.

Breast Cancer Res Treat. 2010 Nov;124(1):237-41. doi: 10.1007/s10549-010-0809-z. Epub 2010 Mar 9.

PMID:
20213080
10.

Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.

Sung H, Lee KM, Choi JY, Han S, Lee JY, Li L, Park SK, Yoo KY, Noh DY, Ahn SH, Kang D.

Breast Cancer Res Treat. 2011 Dec;130(3):939-51. doi: 10.1007/s10549-011-1656-2. Epub 2011 Jul 16.

PMID:
21766210
11.

Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.

Han W, Woo JH, Yu JH, Lee MJ, Moon HG, Kang D, Noh DY.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):793-8. doi: 10.1158/1055-9965.EPI-10-1282. Epub 2011 Mar 17.

12.

Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.

Tutera AM, Sellers TA, Potter JD, Drinkard CR, Wiesner GL, Folsom AR.

Genet Epidemiol. 1996;13(2):207-21.

PMID:
8722747
13.

A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population.

Sueta A, Ito H, Kawase T, Hirose K, Hosono S, Yatabe Y, Tajima K, Tanaka H, Iwata H, Iwase H, Matsuo K.

Breast Cancer Res Treat. 2012 Apr;132(2):711-21. doi: 10.1007/s10549-011-1904-5. Epub 2011 Dec 11.

PMID:
22160591
14.

Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.

Shan J, Mahfoudh W, Dsouza SP, Hassen E, Bouaouina N, Abdelhak S, Benhadjayed A, Memmi H, Mathew RA, Aigha II, Gabbouj S, Remadi Y, Chouchane L.

Breast Cancer Res Treat. 2012 Oct;135(3):715-24. doi: 10.1007/s10549-012-2202-6. Epub 2012 Aug 22.

15.

Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.

Barzan D, Veldwijk MR, Herskind C, Li Y, Zhang B, Sperk E, Du WD, Zhang XJ, Wenz F.

Eur J Hum Genet. 2013 Nov;21(11):1286-92. doi: 10.1038/ejhg.2013.38. Epub 2013 Mar 13.

16.

Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.

Dite GS, Mahmoodi M, Bickerstaffe A, Hammet F, Macinnis RJ, Tsimiklis H, Dowty JG, Apicella C, Phillips KA, Giles GG, Southey MC, Hopper JL.

Breast Cancer Res Treat. 2013 Jun;139(3):887-96. doi: 10.1007/s10549-013-2610-2. Epub 2013 Jun 18.

17.

Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.

Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J, Millikan RC.

Cancer Causes Control. 2015 Jan;26(1):121-31. doi: 10.1007/s10552-014-0491-2. Epub 2014 Nov 25.

18.

Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women.

Gabriel CA, Mitra N, Demichele A, Rebbeck T.

Breast Cancer Res Treat. 2013 Jun;139(3):833-43. doi: 10.1007/s10549-013-2592-0. Epub 2013 Jun 14.

19.

Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.

Haiman CA, Garcia RR, Hsu C, Xia L, Ha H, Sheng X, Le Marchand L, Kolonel LN, Henderson BE, Stallcup MR, Greene GL, Press MF.

BMC Cancer. 2009 Jan 30;9:43. doi: 10.1186/1471-2407-9-43.

20.

Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China.

He X, Yao G, Li F, Li M, Yang X.

Int J Mol Sci. 2014 Jan 29;15(2):2130-41. doi: 10.3390/ijms15022130.

Supplemental Content

Support Center